Market Tracker

01/20 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.30
Delayed Data
As of Jan 20
 +0.0101 / +0.78%
Today’s Change
1.14
Today|||52-Week Range
2.00
+5.69%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.29
Today’s open1.30
Day’s range1.28 - 1.37
Volume41,690
Average volume (3 months)64,942
Market cap$50.2M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.10-5.00%
CAPRCapricor Therapeutic...-0.07-2.97%
EBIOEleven Biotherapeuti...-0.01-0.49%
GLMDGalmed Pharmaceutica...-0.02-0.47%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts